The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3 + T-Regulatory Cells
Open accessAbstract
Foxp3(+) T-regulatory cells (Tregs) are key to immune homeostasis such that their diminished numbers or function can cause autoimmunity and allograft rejection. Foxp3(+) Tregs express multiple histone/protein deacetylases (HDACs) that regulate chromatin remodeling, gene expression, and protein function. Pan-HDAC inhibitors developed for oncologic applications enhance Treg production and Treg suppression function but have limited nononcologic utility given their broad actions and various side effects. We show, using HDAC6-deficient mice and wild-type (WT) mice treated with HDAC6-specific inhibitors, that HDAC6 inhibition promotes Treg suppressive activity in models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection. Many of the beneficial effects of HDAC6 targeting are also achieved by inhibition of the HDAC6-regulated protein heat shock protein 90 (HSP90). Hence, selective targeting of a single HDAC isoform, HDAC6, or its downstream target, HSP90, can promote Treg-dependent suppression of autoimmunity and transplant rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“deacetylation of cortactin (61), -tubulin (24), HSP90 (3, 27), and other proteins, including some, such as tubulin and cortactin, that affect cell migration (54).”
BackgroundHSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153 · cited 2×
“HDAC6 and HSP90 are present in a cytoplasmic complex, and HDAC6 inhibition leads to HSP90 acetylation and disruption of its key chaperone functions (3, 27).”
BackgroundRegulatory T cells exert checks and balances on self tolerance and autoimmunity
Wing, K., & Sakaguchi, S. (2010) · Nature Immunology · doi:10.1038/ni.1818 · Cited by 1,107
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
Self-citationRational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., & Kozikowski, A. P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102758v · Cited by 801
Self-citationThree proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770
Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500186200 · Cited by 755
Self-citationFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736
HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin
Zhang, X., Yuan, Z., Zhang, Y., Yong, S., Salas-Burgos, A., Koomen, J., Olashaw, N., Parsons, J. T., Yang, X.-J., Dent, S. R., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.033 · Cited by 722
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Melgar, S., Karlsson, A., & Michaëlsson, E. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2004 · Cited by 578
Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559 · cited 3×
“HDAC6-selective inhibitors (HDAC6i) (8, 12, 22, 28, 46, 48, 50) and HDAC6 / mice (20, 62) have been developed.”
Self-citationFoxp3+ regulatory T cells: differentiation, specification, subphenotypes
Feuerer, M., Hill, J. A., Mathis, D., & Benoist, C. (2009) · Nature Immunology · doi:10.1038/ni.1760 · Cited by 507
Mouse models of inflammatory bowel disease☆
WIRTZ, S., & NEURATH, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.07.003 · Cited by 507
HDAC6: a key regulator of cytoskeleton, cell migration and cell–cell interactions
Valenzuela-Fernández, A., Cabrero, J. R., Serrador, J. M., & Sánchez-Madrid, F. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.04.003 · Cited by 505
Hancock, W. W., Buelow, R., Sayegh, M. H., & Turka, L. A. (1998) · Nature Medicine · doi:10.1038/3982 · Cited by 453
Self-citationAn Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413 · cited 3×
“4c) or, to a lesser extent, acetylated K294 (Fig.”
BackgroundHuman T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
Riley, J. L., June, C. H., & Blazar, B. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.006 · Cited by 412
Homeostatic proliferation is a barrier to transplantation tolerance
Wu, Z., Bensinger, S. J., Zhang, J., Chen, C., Yuan, X., Huang, X., Markmann, J. F., Kassaee, A., Rosengard, B. R., Hancock, W. W., et al. (2004) · Nature Medicine · doi:10.1038/nm965 · Cited by 401
Self-citationLee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E., & Hancock, W. W. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041709 · Cited by 371
Self-citationHDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Boyault, C., Zhang, Y., Fritah, S., Caron, C., Gilquin, B., Kwon, S. H., Garrido, C., Yao, T.-P., Vourc’h, C., Matthias, P., et al. (2007) · Genes & Development · doi:10.1101/gad.436407 · Cited by 368
Self-citationHistone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
Lee, J.-H., Choy, M. L., Ngo, L., Foster, S. S., & Marks, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008522107 · Cited by 363
Trinklein, N. D., Murray, J. I., Hartman, S. J., Botstein, D., & Myers, R. M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-10-0738 · Cited by 341
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0191 · Cited by 336
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
Marks, P. A. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.510514 · Cited by 281
Duarte, J. H., Zelenay, S., Bergman, M., Martins, A. C., & Demengeot, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200839196 · Cited by 250
Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
de Zoeten, E. F., Wang, L., Sai, H., Dillmann, W. H., & Hancock, W. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.037 · Cited by 239
Self-citationRole of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell Invasion
Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Atadja, P., & Bhalla, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0644 · Cited by 221
Molecularly Targeted Oncology Therapeutics and Prolongation of the QT Interval
Strevel, E. L., Ing, D. J., & Siu, L. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6925 · Cited by 211
Histone Deacetylase 6 Regulates Growth Factor-Induced Actin Remodeling and Endocytosis
Gao, Y.-S., Hubbert, C. C., Lu, J., Lee, Y.-S., Lee, J.-Y., & Yao, T.-P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00393-07 · Cited by 209
Kozikowski, A. P., Tapadar, S., Luchini, D. N., Kim, K. H., & Billadeau, D. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002894 · Cited by 189
Self-citationWang, L., de Zoeten, E. F., Greene, M. I., & Hancock, W. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3031 · Cited by 186
Self-citationDiscovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
Porter, J. R., Fritz, C. C., & Depew, K. M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.019 · Cited by 177
Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells
Sadlon, T. J., Wilkinson, B. G., Pederson, S., Brown, C. Y., Bresatz, S., Gargett, T., Melville, E. L., Peng, K., D’Andrea, R. J., Glonek, G. G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000082 · Cited by 159
Pacey, S., Gore, M. E., Chao, D., Banerji, U., Larkin, J., Sarker, S., Owen, K., Asad, Y. J., Raynaud, F. I., Walton, M., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9493-4 · Cited by 140
Chen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 136
Self-citationHistone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs
Akimova, T., Ge, G., Golovina, T. N., Mikheeva, T., Wang, L., Riley, J. L., & Hancock, W. W. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.04.018 · Cited by 136
Self-citationMayday - integrative analytics for expression data
Battke, F., Symons, S., & Nieselt, K. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-121 · Cited by 118
Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors
Kozikowski, A. P., & Butler, K. V. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783885353 · Cited by 116
Self-citationSuzuki, T., Kouketsu, A., Itoh, Y., Hisakawa, S., Maeda, S., Yoshida, M., Nakagawa, H., & Miyata, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060554y · Cited by 107
Histone deacetylase inhibitors in lymphoma and solid malignancies
Rasheed, W. K., Bishton, M. J., Johnstone, R. W., & Prince, H. M. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.3.413 · Cited by 102
Molecular orchestration of differentiation and function of regulatory T cells
Lu, L., & Rudensky, A. Y. (2009) · Genes & Development · doi:10.1101/gad.1791009 · Cited by 87
Wang, L., Tao, R. N., & Hancock, W. W. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2008.106 · Cited by 85
Self-citationNovel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors
Smil, D. V., Manku, S., Chantigny, Y., Leit, S. M., Wahhab, A., Yan, T. P., Fournel, M., Maroun, C. R., Li, Z., Lemieux, A., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.045 · Cited by 83
Li, D., Xie, S., Ren, Y., Huo, L., Gao, J., Cui, D., Liu, M., & Zhou, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1015-4 · Cited by 79
Schäfer, S., Saunders, L. R., Eliseeva, E. D., Velena, A., Jung, M., Schwienhorst, A., Strasser, A., Dickmanns, A., Ficner, R., Schlimme, S., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.092 · Cited by 71
Non-Peptide Macrocyclic Histone Deacetylase Inhibitors
Oyelere, A. K., Chen, P. C., Guerrant, W., Mwakwari, S. C., Hood, R., Zhang, Y., & Fan, Y. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801128g · Cited by 64
Mudter, J., Wirtz, S. J., Galle, P. R., & Neurath, M. F. (2002) · Pathobiology · doi:10.1159/000068150 · Cited by 60
Sato, T., Kanai∥, T., Watanabe, M., Sakuraba, A., Okamoto, S., Nakai, T., Okazawa, A., Inoue, N., Totsuka, T., Yamazaki, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.011 · Cited by 59
Dejligbjerg, M., Grauslund, M., Litman, T., Collins, L. S., Qian, X., Jeffers, M., Lichenstein, H. S., Jensen, P., & Sehested, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-70 · Cited by 48
Butler, R. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480180 · Cited by 43
Cited by
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246
Self-citationZhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy182 · Cited by 525
Histone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546
Metadata
- Authors
- de Zoeten, E. F., Wang, L., Butler, K., Beier, U. H., Akimova, T., Sai, H., Bradner, J. E., Mazitschek, R., Kozikowski, A. P., Matthias, P., & Hancock, W. W.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-05-01
- Volume
- 31
- Issue
- 10
- Pages
- 2066-2078
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2102489631
- Cited by
- 258
- References
- 62
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.